Extracellular superoxide dismutase and risk of COPD

COPD: Journal of Chronic Obstructive Pulmonary Disease

Volumn 6, Issue 4, 2009, Pages 307-312

  Oberley Deegan, Rebecca E ^a   Regan, Elizabeth A ^a   Kinnula, Vuokko L ^b   Crapo, James D ^a  

^a DEPARTMENT OF MEDICINE   (United States)

^b UNIVERSITY OF HELSINKI   (Finland)

Author keywords

COPD; ECSOD; Free radicals; Genetic Association

Indexed keywords

CIGARETTE SMOKE; FREE RADICAL; SUPEROXIDE DISMUTASE;

ACUTE LUNG INJURY; ANTIOXIDANT ACTIVITY; CHRONIC OBSTRUCTIVE LUNG DISEASE; CIGARETTE SMOKING; CONFERENCE PAPER; EXTRACELLULAR MATRIX; GENE MUTATION; GENETIC POLYMORPHISM; GENETIC RISK; HUMAN; INFLAMMATION; NONHUMAN; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM;

DISEASE PROGRESSION; EXTRACELLULAR SPACE; FREE RADICALS; HUMANS; OXIDATIVE STRESS; POLYMORPHISM, GENETIC; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY FUNCTION TESTS; RISK FACTORS; SMOKING; SUPEROXIDE DISMUTASE;

EID: 70350482921     PISSN: 15412555     EISSN: 15412563     Source Type: Journal    
DOI: 10.1080/15412550903085193     Document Type: Conference Paper

References (54)

1. Lokke A, Lange P, Scharling H, Fabricius P, Vestbo J. Developing COPD: a 25 year follow up study of the general population. Thorax 2006; 61:935-939. (Pubitemid 44787161)
2. Dahl M, Bowler RP, Juul K, Crapo JD, Levy S, Nordestgaard BG. Superoxide dismutase 3 polymorphism associated with reduced lung function in two large populations. Amer J Respir Crit Care Med 2008; 178:906-912.
3. Juul K, Tybjaerg-Hansen A, Marklund S, Lange P, Nordestgaard BG. Genetically increased antioxidative protection and decreased chronic obstructive pulmonary disease. Amer J Respir Crit Care Med 2006; 173:858-864.
4. Kinnula VL, Crapo JD. Superoxide dismutases in the lung and human lung diseases. Amer J Respir Crit CareMed 2003; 167:1600-1619.
5. Tetley TD. Inflammatory cells and chronic obstructive pulmonary disease. Curr Drug Targets 2005; 4:607-618.
6. Yoshida T, Tuder RM. Pathobiology of cigarette smoke-induced chronic obstructive pulmonary disease. Physiol Rev 2007; 87:1047-1082.
7. Church DF, Pryor WA. Free-radical chemistry of cigarette smoke and its toxicological implications. Environ Health Perspect 1985; 64:111-126.
8. Kirkham P, Rahman I. Oxidative stress in asthma and COPD: antioxidants as a therapeutic strategy. Pharmacol Therapeut 2006; 111:476-494.
9. Agius RM, Rutman A, Knight RK, Cole PJ. Human pulmonary alveolar macrophages with smokers' inclusions: their relation to the cessation of cigarette smoking. Br J Exper Pathol 1986; 67:407-413.
10. Iles KE, Forman HJ. Macrophage signaling and respiratory burst. Immunol Res 2002;26:95-105.
11. McCord JM, Gao B, Leff J, Flores SC. Neutrophil-generated free radicals: possiblemechanisms of injury in adult respiratory distress syndrome. Environ Health Perspect 1994;102 Suppl 10:57-60.
12. BiernackiWA, Kharitonov SA, Barnes PJ. Increased leukotriene B4 and 8-isoprostane in exhaled breath condensate of patients with exacerbations of COPD. Thorax 2003;58:294-298.
13. Paredi P, Kharitonov SA, Leak D, Ward S, Cramer D, Barnes PJ. Exhaled ethane, a marker of lipid peroxidation, is elevated in chronic obstructive pulmonary disease. Amer J Respirat Crit Care Med 2000;162:369-373.
14. Pratico D, Basili S, Vieri M, Cordova C, Violi F, Fitzgerald GA. Chronic obstructive pulmonary disease is associated with an increase in urinary levels of isoprostane F2alpha-III, an index of oxidant stress. Amer J Respir Crit Care Med 1998; 158:1709-1714.
15. Rahman I, van Schadewijk AA, Crowther AJ, Hiemstra PS, Stolk J, MacNeeW, De Boer WI. 4-Hydroxy-2-nonenal, a specific lipid peroxidation product, is elevated in lungs of patients with chronic obstructive pulmonary disease. Amer J Respirat Crit Care Med 2002;166:490-495.
16. Corradi M, Pesci A, Casana R, Alinovi R, Goldoni M, Vettori MV, Cuomo A. Nitrate in exhaled breath condensate of patients with different airway diseases. Nitric Oxide 2003; 8:26-30. (Pubitemid 36266700)
17. Ichinose M, Sugiura H, Yamagata S, Koarai A, Shirato K. Increase in reactive nitrogen species production in chronic obstructive pulmonary disease airways. Amer J Respir Critical Care Med 2000; 162:701-706.
18. Kinnula VL, Ilumets H, Myllarniemi M, Sovijarvi A, Rytila P. 8-Isoprostane as a marker of oxidative stress in nonsymptomatic cigarette smokers and COPD. Eur Respir J 2007; 29:51-55.
19. Rytila P, Rehn T, Ilumets H, Rouhos A, Sovijarvi A,Myllarniemi M, Kinnula VL. Increased oxidative stress in asymptomatic current chronic smokers and GOLD stage 0 COPD. Resp Res 2006; 7:69.
20. Nadeem A, Raj HG, Chhabra SK. Increased oxidative stress and altered levels of antioxidants in chronic obstructive pulmonary disease. Inflammation 2005; 29:23-32.
21. Fraig M, Shreesha U, Savici D, Katzenstein AL. Respiratory bronchiolitis: a clinicopathologic study in current smokers, ex-smokers, and never-smokers. Amer J Surg Pathol 2002; 26:647-653.
22. Louhelainen N, Rytila P, Haahtela T, Kinnula VL, Djukanovic R. Persistence of oxidant and protease burden in the airways after smoking cessation. BMC Pulmon Med 2009; 9:25.
23. Hogg JC, Chu F, Utokaparch S, Woods R, Elliott WM, Buzatu L, Cherniack RM, Rogers RM, Sciurba FC, Coxson HO, Pare PD. The nature of small-airway obstruction in chronic obstructive pulmonary disease. New Engl J Med 2004; 350:2645-2653.
24. Bowler RP, Barnes PJ, Crapo JD. The role of oxidative stress in chronic obstructive pulmonary disease. COPD 2004; 1:255-277.
25. Rahman I. The role of oxidative stress in the pathogenesis of COPD: implications for therapy. Treat Respir Med 2005; 4:175-200.
26. McCord JM, Fridovich I. Superoxide dismutase. An enzymic function for erythrocuprein (hemocuprein). J Biol Chem 1969; 244:6049-6055.
27. Marklund SL. Human copper-containing superoxide dismutase of high molecular weight. Proceedings of the National Academy of Sciences of the United States of America79: 7634-7638, 1982.
28. Weisiger RA, Fridovich I. Mitochondrial superoxide dimutase. Site of synthesis and intramitochondrial localization. J Biol Chem 1973; 248:4793-4796.
29. Oury TD, Chang LY, Marklund SL, Day BJ, Crapo JD. Immunocytochemical localization of extracellular superoxide dismutase in human lung. Lab Invest J Tech Meth Pathol 1994; 70:889-898.
30. Oury TD, Day BJ, Crapo JD. Extracellular superoxide dismutase in vessels and airways of humans and baboons. Free Rad Biol Med 1996; 20:957-965.
31. Folz RJ, Crapo JD. Extracellular superoxide dismutase (SOD3): tissue-specific expression, genomic characterization, and computer-assisted sequence analysis of the human EC SOD gene. Genomics 1994; 22:162-171.
32. Inoue M, Watanabe N, Matsuno K, Sasaki J, Tanaka Y, Hatanaka H, Amachi T. Expression of a hybrid Cu/Zn-type superoxide dismutase which has high affinity for heparin-like proteoglycans on vascular endothelial cells. J Biol Chem 1991; 266:16409-16414.
33. Gao F, Kinnula VL, Myllarniemi M, Oury TD. Extracellular superoxide dismutase in pulmonary fibrosis. Antioxidants Redox Signal 2008; 10:343-354.
34. Tan RJ, Fattman CL, Watkins SC, Oury TD. Redistribution of pulmonary EC-SOD after exposure to asbestos. J Appl Physiol 2004; 97:2006-2013.
35. Fattman CL, Tan RJ, Tobolewski JM, Oury TD. Increased sensitivity to asbestos-induced lung injury in mice lacking extracellular superoxide dismutase. Free Rad Biol Med 2006; 40:601-607.
36. Folz RJ, Abushamaa AM, Suliman HB. Extracellular superoxide dismutase in the airways of transgenic mice reduces inflammation and attenuates lung toxicity following hyperoxia. J Clin Invest 1999; 103:1055-1066.
37. Gongora MC, Lob HE, Landmesser U, Guzik TJ, Martin WD, Ozumi K, Wall SM, Wilson DS, Murthy N, Gravanis M, Fukai T, Harrison DG. Loss of extracellular superoxide dismutase leads to acute lung damage in the presence of ambient air: a potential mechanism underlying adult respiratory distress syndrome. Amer J Pathol2008; 173:915-926.
38. Bowler RP, Nicks M, Warnick K, Crapo JD. Role of extracellular superoxide dismutase in bleomycin-induced pulmonary fibrosis. Amer J Physiol2002; 282:L719-726.
39. Bowler RP, Nicks M, Tran K, Tanner G, Chang LY, Young SK, Worthen GS. Extracellular superoxide dismutase attenuates attenuates lipopolysaccharide- induced neutrophilic inflammation. Amer J Respir Cell Mol Biol 2004; 31:432-439.
40. Gao F, Koenitzer JR, Tobolewski JM, Jiang D, Liang J, Noble PW, Oury TD. Extracellular superoxide dismutase inhibits inflammation by preventing oxidative fragmentation of hyaluronan. J Biol Chem 2008; 283:6058-6066.
41. Kliment CR, Tobolewski JM, Manni ML, Tan RJ, Enghild J, Oury TD. Extracellular superoxide dismutase protects against matrix degradation of heparan sulfate in the lung. Antioxidants Redox Signal 2008; 10:261-268.
42. Petersen SV, Oury TD, Ostergaard L, Valnickova Z,Wegrzyn J, Thogersen IB, Jacobsen C, Bowler RP, Fattman CL, Crapo JD, Enghild JJ. Extracellular superoxide dismutase (EC-SOD) binds to type I collagen and protects against oxidative fragmentation. J Biol Chem 2004; 279:13705-13710.
43. Cutroneo KR. TGF-beta-induced fibrosis and SMAD signaling: oligo decoys as natural therapeutics for inhibition of tissue fibrosis and scarring. Wound Repair Regen15 Suppl 1: S54-60, 2007.
44. Rabbani ZN, Anscher MS, Folz RJ, Archer E, Huang H, Chen L, Golson ML, Samulski TS, Dewhirst MW, Vujaskovic Z. Overexpression of extracellular superoxide dismutase reduces acute radiation induced lung toxicity. BMC Cancer2005; 5:59.
45. Cotch MF, Beaty TH, Cohen BH. Path analysis of familial resemblance of pulmonary function and cigarette smoking. Amer Rev Respir Dis 1990; 142:1337-1343.
46. CotchMF, Beaty TH, Munoz A, Cohen BH. Estimating familial aggregation while adjusting for covariates. Application to pulmonary function data from black and white sibships. Ann Epidemiol 1992; 2:317-324.
47. Rybicki BA, Beaty TH, Cohen BH. Major genetic mechanisms in pulmonary function. J Clin Epidemiol 1990; 43:667-675.
48. Silverman EK, Chapman HA, Drazen JM, Weiss ST, Rosner B, Campbell EJ, O'Donnell WJ, Reilly JJ, Ginns L, Mentzer S, Wain J, Speizer FE. Genetic epidemiology of severe, early-onset chronic obstructive pulmonary disease. Risk to relatives for airflow obstruction and chronic bronchitis. Amer J Respir Crit Care Med 1998; 157:1770-1778.
49. Reinhard C, Meyer B, Fuchs H, Stoeger T, Eder G, Ruschendorf F, Heyder J, Nurnberg P, de Angelis MH, Schulz H. Genomewide linkage analysis identifies novel genetic Loci for lung function in mice. Amer J Respir Crit CareMed 2005; 171:880-888.
50. Ganguly K, Stoeger T, Wesselkamper SC, Reinhard C, Sartor MA, Medvedovic M, Tomlinson CR, Bolle I, Mason JM, Leikauf GD, Schulz H. Candidate genes controlling pulmonary function in mice: transcript profiling and predicted protein structure. Physiol Genom2007; 31:410-421.
51. Wilk JB, Walter RE, Laramie JM, Gottlieb DJ, O'Connor GT. Framingham Heart Study genome-wide association: results for pulmonary function measures. BMC Med Genetic s2007; 8 Suppl 1: S8.
52. Arcaroli JJ, Hokanson JE, Abraham E, Geraci M, Murphy JR, Bowler RP, Dinarello CA, Silveira L, Sankoff J, Heyland D, Wischmeyer P, Crapo JD. Extracellular superoxide dismutase haplotypes are associated with acute lung injury and mortality. Amer J Respir Crit Care Med 2009; 179:105-112.
53. Bentley AR, Emrani P, Cassano PA. Genetic variation and gene expression in antioxidant related enzymes and risk of COPD: a systematic review. Thorax 2008; 63:956-961.
54. Young RP, Hopkins R, Black PN, Eddy C, Wu L, Gamble GD, Mills GD, Garrett JE, Eaton TE, Rees MI. Functional variants of antioxidant genes in smokers with COPD and in those with normal lung function. Thorax 2006; 61:394-399.